Compound Summary
Compound Name: | ethosuximide |
Compound CID: | 3291 |
Synonyms: | ethosuximide 77-67-8 Zarontin Etosuximida 2-Ethyl-2-methylsuccinimide More... |
Iupac Name: | 3-ethyl-3-methylpyrrolidine-2,5-dione |
InChI: | InChI=1S/C7H11NO2/c1-3-7(2)4-5(9)8-6(7)10/h3-4H2,1-2H3,(H,8,9,10) |
InChIKey: | HAPOVYFOVVWLRS-UHFFFAOYSA-N |
Canonical Smiles: | CCC1(CC(=O)NC1=O)C |
Isomeric Smiles: | CCC1(CC(=O)NC1=O)C |
Molecular Weight: | 141.17 |
Molecular Formula: | C7H11NO2 |
Molecular Weight: | 141.17 |
Molecular Formula: | C7H11NO2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 1 |
Heavy Atom Count: | 10 |
Complexity: | 188 |
ethosuximide | ethosuximide |
---|---|
ethosuximide |
77-67-8 |
Zarontin |
Etosuximida |
2-Ethyl-2-methylsuccinimide |
Ethosuxide |
Ethosuccimide |
Ethosuccinimide |
Etosuximid |
Petnidan |
Suxinutin |
Atysmal |
Emeside |
Ethymal |
Suxilep |
3-Ethyl-3-methylpyrrolidine-2,5-dione |
Pentinimid |
Peptinimid |
Petinimid |
Pyknolepsinum |
Succimitin |
Zaraondan |
Capitus |
Mesentol |
Pemalin |
Simatin |
Succimal |
Suximal |
Thetamid |
Zarodan |
Zarondan |
Zartalin |
Asamid |
Etomal |
Pemal |
Ronton |
Suxin |
Aethosuximide |
Piknolepsin |
Thilopemal |
Epileo Petit MAL |
Zarondan-Saft |
Simatin(E) |
Ethosuximidum |
3-Methyl-3-ethylsuccinimide |
3-Ethyl-3-methyl-2,5-pyrrolidinedione |
2-Methyl-2-ethylsuccinimide |
2,5-Pyrrolidinedione, 3-ethyl-3-methyl- |
CI-366 |
Succinimide, 2-ethyl-2-methyl- |
3-Ethyl-3-methylsuccinimide |
PM 671 |
PM-671 |
CN-10,395 |
3-Methyl-3-ethylpyrrolidine-2,5-dione |
alpha-Ethyl-alpha-methylsuccinimide |
alpha-Methyl-alpha-ethylsuccinimide |
gamma-Methyl-gamma-ethyl-succinimide |
C.I. 366 |
H 940 |
H-490 |
Cl 366 |
(+-)-2-Ethyl-2-methylsuccinimide |
CN-10395 |
gamma-ethyl-gamma-methyl-succinimide |
NSC-64013 |
3-Ethyl-3-methylpyrroline-2,5-dione |
CHEMBL696 |
.alpha.-Ethyl-.alpha.-methylsuccinimide |
3-ethyl-3-methyl-pyrrolidine-2,5-dione |
CHEBI:4887 |
Aethosuccimidum |
Etosuximide |
NSC64013 |
MFCD00072123 |
.gamma.-Methyl-.gamma.-ethylsuccinimide |
Etosuccimide |
Etosuccimide DCIT |
Aethosuximide German |
DSSTox_CID_3019 |
N-Ethyl methylsuccinimide |
DSSTox_RID_76832 |
DSSTox_GSID_23019 |
Ethosuximidum INN-Latin |
Etosuximida INN-Spanish |
Pyknole.psi.num |
Piknole.psi.n |
Zarontin (TN) |
HSDB 1119 |
SR-01000075863 |
EINECS 201-048-7 |
CI 366 |
NSC 64013 |
BRN 0117054 |
CAS-77-67-8 |
NCGC00016320-01 |
Prestwick_611 |
Ethosuximide USAN:USP:INN:BAN:JAN |
Spectrum_001385 |
Prestwick0_000165 |
Prestwick1_000165 |
Prestwick2_000165 |
Prestwick3_000165 |
Spectrum2_001483 |
Spectrum3_000944 |
Spectrum4_001051 |
Spectrum5_001073 |
E0746 |
(.+/-.)-Ethosuximide |
2, 3-ethyl-3-methyl- |
E 7138 |
NCIOpen2_000014 |
Lopac0_000532 |
SCHEMBL34212 |
BSPBio_000029 |
KBioGR_001342 |
KBioSS_001865 |
5-21-09-00595 (Beilstein Handbook Reference) |
DivK1c_000218 |
SPECTRUM1502196 |
2,5-Pyrrolidinedione, 3-ethyl-3-methyl-, (+-)- |
SPBio_001465 |
SPBio_001950 |
BPBio1_000033 |
GTPL7182 |
WLN: T5VMVTJ D2 D1 |
DTXSID7023019 |
SCHEMBL20541518 |
Ethosuximide (JP17/USP/INN) |
Ethosuximide, analytical standard |
HMS500K20 |
KBio1_000218 |
KBio2_001865 |
KBio2_004433 |
KBio2_007001 |
KBio3_002008 |
AOB5337 |
NINDS_000218 |
HMS1568B11 |
HMS1921L14 |
HMS2092D20 |
HMS2095B11 |
HMS3261L05 |
HMS3712B11 |
HMS3885D12 |
Pharmakon1600-01502196 |
HY-B1378 |
Ethosuximide 1.0 mg/ml in Methanol |
Tox21_110370 |
Tox21_500532 |
(+/-)-2-ethyl-2-methylsuccinimide |
BDBM50240424 |
CCG-39217 |
NSC758192 |
s4626 |
3-ethyl-3-methylazolidine-2,5-dione |
AKOS005261742 |
Tox21_110370_1 |
CS-7976 |
DB00593 |
LP00532 |
MCULE-4034034545 |
NSC-758192 |
SDCCGSBI-0050515.P004 |
.alpha.-Methyl-.alpha.-ethylsuccinimide |
IDI1_000218 |
NCGC00015418-02 |
NCGC00015418-03 |
NCGC00015418-04 |
NCGC00015418-05 |
NCGC00015418-06 |
NCGC00015418-08 |
NCGC00015418-09 |
NCGC00015418-15 |
NCGC00093923-01 |
NCGC00093923-02 |
NCGC00093923-03 |
NCGC00093923-04 |
NCGC00261217-01 |
3-Ethyl-3-methyl-2, 5-pyrrolidinedione |
AS-16859 |
SBI-0050515.P003 |
2, 5-Pyrrolidinedione, 3-ethyl-3-methyl- |
AB00052288 |
EU-0100532 |
FT-0668060 |
FT-0668061 |
ST51037248 |
C07505 |
D00539 |
D70258 |
AB00052288_04 |
zarontin3-Ethyl-3-methyl-pyrrolidine-2,5-dione |
Q421567 |
SR-01000075863-1 |
SR-01000075863-3 |
SR-01000075863-5 |
W-109273 |
3-Ethyl-3-methyl-pyrrolidine-2,5-dione(Ethosuximide) |
BRD-A99633051-001-04-7 |
BRD-A99633051-001-05-4 |
3-Ethyl-3-methyl-pyrrolidine-2,5-dione (ethosuximide) |
Z2379802739 |
3-ethyl-5-hydroxy-3-methyl-3,4-dihydro-2H-pyrrol-2-one |
4-ethyl-5-hydroxy-4-methyl-3,4-dihydro-2H-pyrrol-2-one |
Ethosuximide, European Pharmacopoeia (EP) Reference Standard |
Ethosuximide, United States Pharmacopeia (USP) Reference Standard |
Ethosuximide solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 5.000000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 50.000000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 70.000000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 50.000000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 5.000000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 50.000000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 30.000000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 10.000000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 10.000000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 80.000000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 30.000000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 5.000000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 10.000000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 2.000000000000000 | mg/mL | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 85.000000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 4.000000000000000 | mg/mL | 17.000000000000000 | 22.000000000000000 | S | N2 | 33683565 | Active | |||||
Caenorhabditis elegans | 4.000000000000000 | mg/mL | 14.000000000000000 | -2.000000000000000 | S | N2 | 33683565 | Active | |||||
Caenorhabditis elegans | 2.000000000000000 | mg/mL | 13.000000000000000 | 24.000000000000000 | S | N2 | 33683565 | Active | |||||
Caenorhabditis elegans | 2.000000000000000 | mg/mL | 16.700000000000000 | 19.600000000000000 | 17.000000000000000 | 23.300000000000000 | 28.500000000000000 | 22.000000000000000 | S | N2 | 15653505 | Active | |
Caenorhabditis elegans | 32.000000000000000 | S | N2 | 16872777 | Active | ||||||||
Caenorhabditis elegans | 33.000000000000000 | umol/L | 3.000000000000000 | NS | N2 | 24134630 | Inactive | ||||||
Caenorhabditis elegans | 4.000000000000000 | mg/mL | 35.000000000000000 | 37.000000000000000 | S | N2 | 33683565 | Active | |||||
Caenorhabditis elegans | 2.000000000000000 | mg/mL | 16.700000000000000 | 18.900000000000000 | 13.000000000000000 | 23.300000000000000 | 28.900000000000000 | 24.000000000000000 | S | N2 | 15653505 | Active |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 35.000000000000000 | 37.000000000000000 | 4 | 23 |